Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: US-guided Erector spinae Plane block using 20ml of 0.25%. Bupivacaine along with GA: Group I Will receive US-guided Erector spinae Plane block using 20ml of 0.25%. Bupivacaine along wit
Sponsors
All India Institute of Medical Sciences,Patna
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients willing to give written informed consent 2. Aged 18-65 years 3. ASA I –II patients scheduled to undergo elective MRM surgery under GA
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the requirement of postoperative opioid consumptionTimepoint: To compare the requirement of postoperative opioid consumption | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Intraoperative opioid consumption 2.To determine time of first rescue analgesic administration 3.To measure average pain NRS score at 24 hour postoperatively period 4.Satisfaction score assessment 5. To evaluate any adverse effect Timepoint: To measure average pain NRS score at 24 hour postoperatively period (30 minutes, 2 hour, 4 hour, 8 hour, 12 hour, 24 hour) | — |
Countries
India
Contacts
Public ContactAthira Ramesh
All India Institute of Medical Sciences,Patna
Outcome results
None listed